The MS impairment scale: a pragmatic approach to the assessment of impairment in patients with multiple sclerosis

Abstract

We developed a measurement scale for assessment of impairment in MS patients (MSIS) in accordance with the recommandations of WHO. The items were kept close to a standard neurologic examination, and a short battery of cognitive tests was added. Normality was assigned to the value, zero, and the theoretical maximum score was 204. Two-hundred and ten multiple sclerosis (MS) patients were rated by one neurologist on the MS Impairment Scale (MSIS), the Extended Disability Status Scale (EDSS), and the Ambulation Index (AI). The median MSIS score was 52 (5- 147), the median EDSS 6.5 (1 - 9.5), and the median Al 5 (1-5). The relation between the MSIS scores and the EDSS was best described by an exponential function (non-linear regression coefficient, R=0.87). Sixty-two of the patients were reexamined and rated by another neurologist The interrater reliability coefficient (R) of the MSIS was 0.95, of the EDSS 0.91, and of the Al 0.94. Forty patients were examined twice by the first neurologist The intrarater reliability coefficient was 0.97 for the MSIS, 0.95 for the EDSS, and 0.98 for the Al. The MSIS is easy to use and is robust to observer dissimilarities. It has a monomodal univariate distribution and has a better discriminatory power than the EDSS, especially in the EDSS range 6 - 9, while the interrater reliability of the MSIS is at least as good as that of the EDSS and the Al.

Keywords

multiple sclerosis impairment clinical assessment reliability validity

Get full access to this article

View all access options for this article.

References

Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 33: 1444 - 1452.

Sipe JC et al. (1984) A neurologic rating scale (NRS) for use in multiple sclerosis. Neurology 34: 1368 - 1372.

Mickey MR , Ellison GW , Myers LW (1984) An illness severity score for multiple sclerosis . Neurology 34: 1343 - 1347.

Hauser SL et al. (1985) Intensive immunosuppression in progressive multiple sclerosis. New Eng JMed 308: 173- 180.

Amato MP et al. (1988) Interrater reliability in assessing functional systems and disability on the Kurtzke scale in multiple sclerosis. Arch Neurol 45: 746 - 748.

Noseworthy JH et al. (1990) Interrater variability with Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. Neurology 40: 971 - 975.

Lycke J. et al. (1996) Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study. J Neurol 243: 214 - 224.

Tourtelotte W. et al. (1965) Quantitative clinical neurological testing I: A battery of tests designed to evaluate in part the neurological function of patients with multiple sclerosis and its use in a therapeutic trail. Annals of the New York Academy of Science 122: 480 - 505.

Potvin AR , Tourtelotte WW (1985) Quantitative examination of neurologic functions . CRC Press, Boca Raton.

10.

Folstein MF , Folstein SE , McHugh PR (1975) 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician . J Psychiatr Res 12: 189 - 198.

11.

Buschke H. (1973) Selective reminding for analysis of memory and learning. J Verb Learn Beh 12: 543 - 550.

12.

Koziol JA et al. (1996) A comparison of two neurologic scoring instruments for multiple sclerosis. J Neurol 243: 209 - 213.